Records containing: Solid Tumor
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-08-03A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 When Used in Combinations With Selected Anti-Cancer Treatment Regimens in Patients With Selected Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-08-01Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy
-
CLINICAL_TRIALS study record update · 2025-08-01A Phase 1, Dose Escalation Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
-
CLINICAL_TRIALS study record update · 2025-08-01A Phase I Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of HDM2020 (FGFR2b-ADC) in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-07-30Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-07-28A Phase 1, 2-Part Study to Evaluate the Effect of Food on Pharmacokinetics of Pelabresib (CPI-0610) and the Effect of Pelabresib on QTc in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2025-07-25Phase II Trial of Pembrolizumab and Lenvatinib for Leptomeningeal Metastases
-
CLINICAL_TRIALS study record update · 2025-07-25Open and Incremental Phase I Clinical Trial of Recombinant Human GM-CSF Type II Herpes Simplex Virus (OH2) Injection (Vero Cells) in the Treatment of Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-07-24A Phase I First-in-human, Open Label, Multicenter, Dose Escalation and Cohort Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of BB-1705 in Patients With Locally Advanced/Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-07-22A Phase 2 Study of TL118 for the Treatment of Patients With Solid Tumors Harboring NTRK Gene Fusions
-
CLINICAL_TRIALS study record update · 2025-07-22Positron Emission Tomography (PET) Imaging of the Enhanced Permeability and Retention (EPR) Effect With [89Zr]DFO-starPEG in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-07-18Imaging of Solid Tumors Using 18F-TRX
-
CLINICAL_TRIALS study record update · 2025-07-16Open-label, Dose-escalation Trial to Evaluate the Safety and Pharmacokinetics of GEN1046 in Japanese Subjects With Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2025-07-1568Ga-MY6349 PET/CT in Solid Tumors and Compared With 18F-FDG PET/CT
-
CLINICAL_TRIALS study record update · 2025-07-15A Phase I Clinical Study of the Pharmacokinetics and Safety of Technetium [99mTc]-H7ND Injection in Patients With Gastrointestinal Malignancies and Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2025-07-10A Phase 1, Dose-Escalation and Expansion Trial of PT2977, a HIF-2α Inhibitor, in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-07-09A First-in-human Dose-escalation and Expansion Trial With the Antibody-drug Conjugate BYON3521 to Evaluate the Safety, Pharmacokinetics and Efficacy in Patients With c-MET Expressing Locally Advanced or Metastatic Solid Tumours
-
CLINICAL_TRIALS study record update · 2025-07-09A Phase 1/2 Open Label, Dose Escalation and Expansion Study of MDNA11, IL-2 Superkine, Administered Alone or in Combination With Immune Checkpoint Inhibitor in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-07-08A First in Human Phase 1-2 Open-Label, Multicenter, Dose Escalation and Expansion Study of PRS-344/S095012 in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-07-08Design and Implementation of a Social Cognitive Theory-based Medication Adherence Intervention
-
CLINICAL_TRIALS study record update · 2025-07-03A Multicenter, Open-Label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-07-02LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers
-
CLINICAL_TRIALS study record update · 2025-07-02Phase I/IIa, First-in-human, Open-label, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-07-02Phase 1/1b Study of the Safety of TTX-030 as a Single Agent and in Combination With Pembrolizumab or Chemotherapy in Patients With Lymphoma or Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2025-07-02A First-In-Human (FIH) Phase I/II Open-label, Multicentre, Dose Escalation and Expansion Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors Including Non-small Cell Lung Cancer (NSCLC) Harboring Mesenchymal-Epithelial Transition (MET) Alterations